Nasdaq · Healthcare
Cronos Group Inc. (CRON)
As-reported financials and recent SEC filings for Cronos Group Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$146.6M
Net income
$-9.4M
Net margin
-6.4%
Diluted EPS
$-0.02
ROE
-0.8%
P/E (TTM)
—
Market cap
—
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $146.6M | $117.6M | $87.2M | $86.7M | $64.6M |
| Gross profit | — | — | — | — | — |
| Operating income | $-17.4M | $-76.5M | $-84.8M | $-111.4M | $-292.0M |
| Net income | $-9.4M | $41.1M | $-74.0M | $-168.7M | $-396.1M |
| Diluted EPS | $-0.02 | $0.11 | $-0.19 | $-0.45 | $-1.07 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
32026-06-30
View on EDGAR →8-K2026-06-22
View on EDGAR →SD2026-05-29
View on EDGAR →42026-05-14
View on EDGAR →42026-05-14
View on EDGAR →42026-05-14
View on EDGAR →42026-05-14
View on EDGAR →42026-05-12
View on EDGAR →Largest Healthcare peers
Go deeper on CRON
Search Cronos Group Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.